Stefan Wiemann

Head of Division

German Cancer Research Center (DKFZ)

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stefan Wiemann is the Head of Division at the German Cancer Research Center (DKFZ) in Germany. His research focuses on cancer biology, particularly in areas such as autophagy regulation, drug resistance in lung cancer, and the genomic landscape of various malignancies. Recent publications highlight his work on ERBB signaling in breast cancer and the characterization of molecular heterogeneity in colorectal cancer liver metastases.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Yuya Haga

Assistant Professor

Osaka University

JAPAN

View details

Svenja Kemmer

University of Freiburg

GERMANY

View details

Hanibal Bohnenberger

University Medical Center Göttingen

GERMANY

View details

Michael Michal

CZECH REPUBLIC

View details

Kerstin Menck

University Hospital Münster

GERMANY

View details

Tim Beißbarth

Head of department

Universitätsmedizin Göttingen

GERMANY

View details

Fulvia Ferrazzi

University Hospital Erlangen

GERMANY

View details

Jens Timmer

Professor

University of Freiburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefan Wiemann

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

GRB2 is a BECN1 interacting protein that regulates autophagy

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome

Disentangling ERBB Signaling in Breast Cancer Subtypes—A Model-Based Analysis

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.

The genomic and transcriptional landscape of primary central nervous system lymphoma.

A Dual HiBiT-GFP-LC3 Lentiviral Reporter for Autophagy Flux Assessment.

Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors

Cancer-Associated Fibroblasts: Implications for Cancer Therapy

Lipomatous solitary fibrous tumors harbor rare NAB2-STAT6 fusion variants and show upregulation of the gene Peroxisome Proliferator Activated Receptor Gamma (PPARG) encoding for a regulator of adipocyte differentiation.

Collaborators (8)

Yuya Haga

Svenja Kemmer

Hanibal Bohnenberger

Michael Michal

Kerstin Menck

Tim Beißbarth

Fulvia Ferrazzi

Jens Timmer

Make your next move.